Clinical trial
Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type…
NCT00060931 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00060931 |
|---|---|
| Title | Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension |
| Official title | A Randomized, Double-Blind, Multicenter Study Comparing the Effects of Carvedilol and Metoprolol on Glycemic Control in Hypertensive Patients With Type II Diabetes Mellitus. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | carvedilol, metoprolol |
| Enrollment | 501 |
| Start date | Jun 1, 2001 |
| Primary completion | Apr 1, 2004 |
| Completion | Apr 1, 2004 |
| First posted | May 16, 2003 |
| Last update posted | Apr 14, 2015 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: